FDA Class I Recall: Methocarbamol Injection for Particulate Matter
Eugia US LLC is recalling Methocarbamol Injection nationwide due to particulate matter contamination. The FDA classified this as a Class I recall affecting lot 3MC23011 (expiration 11/30/2026).
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: FDA Class I recalls are the agency's most serious classification, indicating a reasonable probability that use will cause serious adverse health consequences. Per the rubric, FDA Class I recalls are never scored below 4. No reported illnesses or deaths are mentioned in the source, preventing a score of 5.
Plain-English summary
Eugia US LLC is recalling Methocarbamol Injection, USP 1000 mg/10 mL, due to the presence of particulate matter. The FDA has classified this as a Class I recall—the most serious classification—indicating a reasonable probability that use of this product may cause serious adverse health consequences.
The affected product is lot 3MC23011 with an expiration date of 11/30/2026. Approximately 1,552 cartons, each containing 25 single-dose vials, were distributed nationwide. The product's NDC number is 55150-223-10.
Methocarbamol is a centrally-acting muscle relaxant administered by intramuscular or intravenous injection. The presence of particulate matter in injectable medications poses a potential risk to patients receiving these injections.
Patients and healthcare providers with vials from the affected lot should stop use immediately and consult with a healthcare provider regarding appropriate next steps.
The recalled product
- Product
- METHOCARBAMOL (METHOCARBAMOL)
- Brand
- METHOCARBAMOL
- Manufacturer
- Eugia US LLC
- Category
- Drug — Injectable
- Hazard
- particulate-matter
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 3MC23011
- Exp 11/30/2026
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · METHOCARBAMOL
- HighMethocarbamol injection recalled for lack of sterility assurance
FDA (Drugs) · 2025-04-16
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27